G-CSFR antagonism reduces mucosal injury and airways fibrosis in a virus-dependent model of severe asthma.
Hao WangChristian AloeJonathan McQualterAngelica PapanicolaouRoss VlahosNick WilsonSteven BozinovskiPublished in: British journal of pharmacology (2021)
We have shown that antagonising G-CSFR-dependent neutrophilic inflammation reduced pathological disruption of the mucosal barrier and airways fibrosis in an IAV-induced severe asthma model.